TOMTOM NV (TOM2.AS) Stock Fundamental Analysis

AMS:TOM2 • NL0013332471

5.125 EUR
-0.04 (-0.87%)
Last: Feb 16, 2026, 07:00 PM
Fundamental Rating

3

Overall TOM2 gets a fundamental rating of 3 out of 10. We evaluated TOM2 against 118 industry peers in the Software industry. TOM2 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TOM2 has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • TOM2 had negative earnings in the past year.
  • TOM2 had a positive operating cash flow in the past year.
  • In the past 5 years TOM2 always reported negative net income.
  • In multiple years TOM2 reported negative operating cash flow during the last 5 years.
TOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFTOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

  • TOM2 has a Return On Assets of -2.47%. This is in the lower half of the industry: TOM2 underperforms 61.86% of its industry peers.
  • With a Return On Equity value of -13.13%, TOM2 is not doing good in the industry: 70.34% of the companies in the same industry are doing better.
  • TOM2 has a Return On Invested Capital (2.14%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.47%
ROE -13.13%
ROIC 2.14%
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
TOM2.AS Yearly ROA, ROE, ROICTOM2.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

  • TOM2 has a Operating Margin (2.34%) which is in line with its industry peers.
  • TOM2's Gross Margin of 88.02% is amongst the best of the industry. TOM2 outperforms 84.75% of its industry peers.
  • In the last couple of years the Gross Margin of TOM2 has grown nicely.
Industry RankSector Rank
OM 2.34%
PM (TTM) N/A
GM 88.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
TOM2.AS Yearly Profit, Operating, Gross MarginsTOM2.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

  • TOM2 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for TOM2 has been reduced compared to 1 year ago.
  • TOM2 has less shares outstanding than it did 5 years ago.
  • TOM2 has a worse debt/assets ratio than last year.
TOM2.AS Yearly Shares OutstandingTOM2.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOM2.AS Yearly Total Debt VS Total AssetsTOM2.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • The Debt to FCF ratio of TOM2 is 4.48, which is a neutral value as it means it would take TOM2, 4.48 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.48, TOM2 is in line with its industry, outperforming 49.15% of the companies in the same industry.
  • A Debt/Equity ratio of 0.23 indicates that TOM2 is not too dependend on debt financing.
  • TOM2 has a Debt to Equity ratio (0.23) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 4.48
Altman-Z N/A
ROIC/WACC0.27
WACC7.88%
TOM2.AS Yearly LT Debt VS Equity VS FCFTOM2.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.71 indicates that TOM2 should not have too much problems paying its short term obligations.
  • TOM2 has a Current ratio of 1.71. This is in the better half of the industry: TOM2 outperforms 61.86% of its industry peers.
  • A Quick Ratio of 1.67 indicates that TOM2 should not have too much problems paying its short term obligations.
  • The Quick ratio of TOM2 (1.67) is better than 63.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.67
TOM2.AS Yearly Current Assets VS Current LiabilitesTOM2.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 28.08% over the past year.
  • TOM2 shows a decrease in Revenue. In the last year, the revenue decreased by -1.70%.
  • TOM2 shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.90% yearly.
EPS 1Y (TTM)28.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%275%
Revenue 1Y (TTM)-1.7%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%-2.7%

3.2 Future

  • Based on estimates for the next years, TOM2 will show a very strong growth in Earnings Per Share. The EPS will grow by 72.93% on average per year.
  • The Revenue is expected to grow by 7.40% on average over the next years.
EPS Next Y25%
EPS Next 2Y114.44%
EPS Next 3Y72.93%
EPS Next 5YN/A
Revenue Next Year-2.86%
Revenue Next 2Y-0.8%
Revenue Next 3Y0.42%
Revenue Next 5Y7.4%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TOM2.AS Yearly Revenue VS EstimatesTOM2.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
TOM2.AS Yearly EPS VS EstimatesTOM2.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

4

4. Valuation

4.1 Price/Earnings Ratio

  • TOM2 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 20.72 indicates a rather expensive valuation of TOM2.
  • Based on the Price/Forward Earnings ratio, TOM2 is valued a bit cheaper than the industry average as 61.86% of the companies are valued more expensively.
  • TOM2's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE N/A
Fwd PE 20.72
TOM2.AS Price Earnings VS Forward Price EarningsTOM2.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TOM2 is valued cheaper than 91.53% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as TOM2.
Industry RankSector Rank
P/FCF 74.31
EV/EBITDA 5.78
TOM2.AS Per share dataTOM2.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as TOM2's earnings are expected to grow with 72.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.44%
EPS Next 3Y72.93%

0

5. Dividend

5.1 Amount

  • TOM2 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

TOMTOM NV

AMS:TOM2 (2/16/2026, 7:00:00 PM)

5.125

-0.04 (-0.87%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-04
Earnings (Next)04-16
Inst Owners18.59%
Inst Owner ChangeN/A
Ins Owners51.4%
Ins Owner ChangeN/A
Market Cap640.63M
Revenue(TTM)565.73M
Net Income(TTM)-17.25M
Analysts76.36
Price Target6.35 (23.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.18%
PT rev (3m)4.18%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-7.69%
EPS NY rev (3m)-16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.72
P/S 1.13
P/FCF 74.31
P/OCF 18
P/B 4.87
P/tB N/A
EV/EBITDA 5.78
EPS(TTM)-0.15
EYN/A
EPS(NY)0.25
Fwd EY4.83%
FCF(TTM)0.07
FCFY1.35%
OCF(TTM)0.28
OCFY5.55%
SpS4.53
BVpS1.05
TBVpS-0.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.47%
ROE -13.13%
ROCE 2.86%
ROIC 2.14%
ROICexc 5.05%
ROICexgc N/A
OM 2.34%
PM (TTM) N/A
GM 88.02%
FCFM 1.52%
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 4.48
Debt/EBITDA 0.86
Cap/Depr 119.93%
Cap/Sales 4.77%
Interest Coverage 7.61
Cash Conversion 99.6%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.67
Altman-Z N/A
F-Score6
WACC7.88%
ROIC/WACC0.27
Cap/Depr(3y)20.27%
Cap/Depr(5y)16.21%
Cap/Sales(3y)1.63%
Cap/Sales(5y)1.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%275%
EPS Next Y25%
EPS Next 2Y114.44%
EPS Next 3Y72.93%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.7%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%-2.7%
Revenue Next Year-2.86%
Revenue Next 2Y-0.8%
Revenue Next 3Y0.42%
Revenue Next 5Y7.4%
EBIT growth 1Y153.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year231.43%
EBIT Next 3Y82.1%
EBIT Next 5YN/A
FCF growth 1Y260.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y643.79%
OCF growth 3Y-66.75%
OCF growth 5Y-57.16%

TOMTOM NV / TOM2.AS FAQ

What is the ChartMill fundamental rating of TOMTOM NV (TOM2.AS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to TOM2.AS.


What is the valuation status for TOM2 stock?

ChartMill assigns a valuation rating of 4 / 10 to TOMTOM NV (TOM2.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for TOMTOM NV?

TOMTOM NV (TOM2.AS) has a profitability rating of 2 / 10.


How financially healthy is TOMTOM NV?

The financial health rating of TOMTOM NV (TOM2.AS) is 4 / 10.